PubMed Health⌕ Search

PubMed · 11685928

Urologic laparoscopy.

Abstract

Urologic laparoscopy initially was confined to a diagnostic role or the treatment of benign conditions. Many of these initial procedures, however, have been abandoned because they offered no significant benefit over open surgery. The treatment of urologic malignancies, however, recently has emerged as the most common indication for laparoscopic urologic surgery. Maturing data for laparoscopic radical nephrectomy, nephroureterectomy and partial nephrectomy demonstrate equivalent oncologic results. Newer applications such as laparoscopic radical prostatectomy are evolving. Despite these data demonstrating many advantages as compared with open techniques, urologists have been slow to include laparoscopy in their practice. This reluctance has been seen in other disciplines and is no doubt, at least in part, caused by the steep learning curve. Laparoscopic management of urologic malignancies is complicated and difficult to learn. In a multi-institutional review of laparoscopic complications, 71% of the complications occurred in the first 20 cases. The risk of complications and operative time significantly declines with experience, however. Higashihara et al reported a decline in laparoscopic operative time to levels comparable to open radical nephrectomy. The learning curve seems to be approximately 30 to 40 cases. The scope and practice of urology does not provide a common procedure of relatively low complexity such as the general surgical cholecystectomy or gynecologic tubal ligation to facilitate the adoption of laparoscopy by urologists. Nevertheless, evolving techniques and equipment coupled with the incorporation of laparoscopic training in residency and fellowship programs will help secure laparoscopy a prominent place in the treatment of urologic malignancy.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

C L Jackson. 2001. Urologic laparoscopy.. https://pubmed.ncbi.nlm.nih.gov/11685928/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Cytosolic glucocorticoid receptor interaction with nuclear factor-kappa B proteins in rat liver cells.

The glucocorticoid receptor (GR) acts as an anti-inflammatory factor. To a large extent, this activity is exerted by the interference of pro-inflammatory nuclear factor kappa B (NF-kappa B) activity. In their respective inactive forms, both GR and NF-kappa B reside in the cytoplasm and translocate to the nucleus on relevant stimulation. Previously, p65, a component of the NF-kappa B complex, and GR have been shown to interact physically in vitro, and the interaction is assumed to take place in the nucleus of cells [McKay and Cidlowski (1999) Endocrine Rev. 20, 435-459]. We have studied the interaction between GR and NF-kappa B using in vivo -like conditions. Using immunoaffinity chromatography or immunoprecipitation, combined with Western blotting, we observed that, with endogenous protein levels in cytosolic extracts of rat liver and of H4-II-E-C3 hepatoma cells and in contrast with the current belief, p65, p50 and inhibitory kappa B alpha complex interact with GR, even in the absence of glucocorticoid or an inflammatory signal. The interaction between non-liganded/non-activated GR and p65/p50 has also been verified by both p65 and p50 co-immunoprecipitations. Intracellular localization studies, using Western blotting, revealed that glucocorticoids can decrease tumour necrosis factor alpha (TNFalpha)-induced nuclear entry of p65, whereas glucocorticoid-induced GR translocation was much less affected by TNFalpha. We were also able to demonstrate a nuclear interaction of GR and p65 and p50 using in vivo -like protein concentrations. Furthermore, nuclear GR interaction with heat-shock protein 90 was enhanced distinctly by TNFalpha treatment. In conclusion, our studies suggest a strong interconnectivity between the NF-kappa B and GR-signalling pathways where also, somewhat unexpectedly, a physical interaction in the cytosol constitutes an integral part of GR-NF-kappa B cross-talk.

Adrenalectomy↗

Sex differences in the conditioned rewarding effects of cocaine.

Several recent reports have demonstrated sex differences in the behavioral and neurochemical response to cocaine. However, it is not clear whether differences exist in cocaine reward or the extent to which adrenal hormones regulate cocaine-induced conditioned place preference (CPP) in either sex. To address these questions, side-by-side comparisons were conducted to determine the effects of conditioning length, cocaine dose and adrenalectomy on cocaine CPP in male and female rats. Female rats demonstrated cocaine CPP after four pairing sessions, while male rats required eight pairing sessions to develop CPP for cocaine. Also, female rats developed CPP at cocaine doses of 5 and 10 mg/kg while male rats required higher cocaine doses (20 mg/kg). Overall, females had higher blood serum levels of corticosterone. Furthermore, a dose-dependent effect on serum levels of corticosterone was observed only in female rats, where rats conditioned with 20 mg/kg cocaine had significantly higher serum levels of corticosterone than rats conditioned with 5 mg/kg cocaine. However, adrenalectomy did not affect CPP for cocaine in either sex. These results suggest that a female's higher sensitivity to cocaine's rewarding effects is not completely mediated by the hypothalamic-pituitary-adrenal axis. Therefore, sex differences in the acquisition and/or expression of cocaine CPP may be regulated by other mechanisms, such as the hypothalamic-pituitary-gonadal axis.

Adrenalectomy↗

The effects of long-term adrenalectomy on 5-HT1B receptors mRNA expression in cerebellum, striatum, frontal cortex and hippocampus of rats.

The brain serotonin (5-HT) system and circulating corticosteroids are in close interaction and both implicated in the pathogenesis of affective disorders. We evaluated the effects of adrenalectomy (ADX) on 5-HT(1B) receptors mRNA expression in cerebellum, frontal cortex, striatum and hippocampus in rats, using the RNase protection assay technique. Eight weeks after bilateral adrenalectomy, 5-HT(1B) receptor mRNA levels were decreased in the cerebellum and in the frontal cortex. The expression of 5-HT(1B) receptors mRNA was unchanged in the hippocampus and in the striatum. This data indicates regional differences in the effects of long term adrenalectomy on the expression of 5-HT(1B) receptors.

Adrenalectomy↗